相似文献
1
Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care.价格透明度面向谁？寻找自付费用估算以促进癌症护理中的成本沟通。
Pharmacoeconomics. 2018 Mar;36(3):259-261. doi: 10.1007/s40273-018-0613-x.
2
Crowdsourcing healthcare costs: Opportunities and challenges for patient centered price transparency.众包医疗成本：以患者为中心的价格透明度的机遇与挑战。
Healthc (Amst). 2016 Mar;4(1):3-5. doi: 10.1016/j.hjdsi.2015.06.004. Epub 2015 Jul 2.
3
Implementing routine communication about costs of cancer treatment: perspectives of providers, patients, and caregivers.实施癌症治疗费用的常规沟通：提供者、患者和护理人员的观点。
Support Care Cancer. 2020 Sep;28(9):4255-4262. doi: 10.1007/s00520-019-05274-2. Epub 2020 Jan 3.
4
Pediatric Price Transparency: Still Opaque With Opportunities for Improvement.儿科价格透明度：仍不透明且有改进空间。
Hosp Pediatr. 2017 Oct;7(10):565-571. doi: 10.1542/hpeds.2017-0020. Epub 2017 Sep 5.
5
Understanding patients' attitudes toward communication about the cost of cancer care.了解患者对癌症护理费用沟通的态度。
J Oncol Pract. 2012 Jul;8(4):e50-8. doi: 10.1200/JOP.2011.000418. Epub 2012 Feb 28.
6
The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature.美国癌症治疗自付费用的影响：文献的批判性评价
Future Oncol. 2014 Nov;10(14):2189-99. doi: 10.2217/fon.14.130.
7
Cancer cost communication: experiences and preferences of patients, caregivers, and oncologists-a nationwide triad study.癌症成本沟通：患者、护理人员和肿瘤医生的经验和偏好——一项全国性三方研究。
Support Care Cancer. 2018 Oct;26(10):3517-3526. doi: 10.1007/s00520-018-4201-6. Epub 2018 Apr 25.
8
Patient-physician communication about out-of-pocket costs.医患之间关于自付费用的沟通。
JAMA. 2003 Aug 20;290(7):953-8. doi: 10.1001/jama.290.7.953.
9
First steps towards price transparency: comparability of online out-of-pocket tools from Australian private health funds.迈向价格透明度的第一步：比较澳大利亚私人健康基金的在线自费工具的可比性。
Aust Health Rev. 2020 Jun;44(3):347-354. doi: 10.1071/AH19109.
10
The utility of cost discussions between patients with cancer and oncologists.癌症患者与肿瘤学家之间成本讨论的效用。
Am J Manag Care. 2015 Sep;21(9):607-15.
引用本文的文献
1
Price transparency in Iranian healthcare market.伊朗医疗保健市场的价格透明度。
Health Policy Open. 2024 Apr 27;6:100120. doi: 10.1016/j.hpopen.2024.100120. eCollection 2024 Dec.
2
Career disruption and limitation of financial earnings due to cancer.癌症导致的职业中断和经济收入受限。
JNCI Cancer Spectr. 2023 Jul 3;7(4). doi: 10.1093/jncics/pkad044.
3
Financial burden among cancer patients: A national-level perspective.癌症患者的经济负担：国家层面的视角。
Cancer Med. 2023 Feb;12(4):4638-4646. doi: 10.1002/cam4.5049. Epub 2022 Jul 19.
4
Cancer-Related Care Costs and Employment Disruption: Recommendations to Reduce Patient Economic Burden as Part of Cancer Care Delivery.癌症相关护理费用与就业中断：作为癌症护理服务一部分减轻患者经济负担的建议。
J Natl Cancer Inst Monogr. 2022 Jul 5;2022(59):79-84. doi: 10.1093/jncimonographs/lgac006.
5
BITES study: A qualitative analysis among emergency medicine physicians on snake envenomation management practices.BITES 研究：对急诊医师进行蛇咬伤管理实践的定性分析。
PLoS One. 2022 Jan 7;17(1):e0262215. doi: 10.1371/journal.pone.0262215. eCollection 2022.
6
Financial Hardship in Survivorship Care Delivery.生存者照护提供中的经济困难。
J Natl Cancer Inst Monogr. 2021 Sep 3;2021(57):10-14. doi: 10.1093/jncimonographs/lgaa012.
7
Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market.废弃的基于体重的抗肿瘤药物给私人保险市场的支付方和患者带来的经济负担。
JNCI Cancer Spectr. 2021 May 18;5(4). doi: 10.1093/jncics/pkab045. eCollection 2021 Aug.
8
Communication research at the National Cancer Institute, 2013-2019: a grant portfolio analysis.国家癌症研究所 2013-2019 年的传播研究：赠款组合分析。
Cancer Causes Control. 2021 Dec;32(12):1333-1345. doi: 10.1007/s10552-021-01481-7. Epub 2021 Jul 27.
9
Delivery of Financial Navigation Services Within National Cancer Institute-Designated Cancer Centers.国家癌症研究所指定癌症中心内的财务导航服务提供。
JNCI Cancer Spectr. 2021 Apr 9;5(3). doi: 10.1093/jncics/pkab033. eCollection 2021 Jun.
10
Protocol for studying the efficiency of ChemoCalc software in helping patients to understand drug treatment costs for breast cancer: A multicenter, open-label, randomized phase 2 study.研究ChemoCalc软件在帮助患者理解乳腺癌药物治疗费用方面效率的方案：一项多中心、开放标签、随机2期研究。
Contemp Clin Trials Commun. 2021 Feb 11;21:100739. doi: 10.1016/j.conctc.2021.100739. eCollection 2021 Mar.
本文引用的文献
1
As if the disease was not enough: coping with the financial consequences of cancer.似乎疾病还不够：应对癌症带来的经济后果。
Support Care Cancer. 2018 Mar;26(3):975-987. doi: 10.1007/s00520-017-3918-y. Epub 2017 Oct 11.
2
Offering A Price Transparency Tool Did Not Reduce Overall Spending Among California Public Employees And Retirees.提供价格透明度工具并未降低加利福尼亚州公共雇员和退休人员的总体支出。
Health Aff (Millwood). 2017 Aug 1;36(8):1401-1407. doi: 10.1377/hlthaff.2016.1636.
3
Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.靶向口服抗癌药物价格上涨及其给医疗保险受益人群带来的相关经济负担。
J Clin Oncol. 2017 Aug 1;35(22):2482-2489. doi: 10.1200/JCO.2017.72.3742. Epub 2017 May 4.
4
Do Patients and Oncologists Discuss the Cost of Cancer Treatment? An Observational Study of Clinical Interactions Between African American Patients and Their Oncologists.患者与肿瘤学家会讨论癌症治疗费用吗？一项关于非裔美国患者与其肿瘤学家临床互动的观察性研究。
J Oncol Pract. 2017 Mar;13(3):e249-e258. doi: 10.1200/JOP.2016.015859. Epub 2016 Dec 13.
5
A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment.肿瘤学中的成本沟通综述：患者态度、提供者接受度和结果评估。
Cancer. 2017 May 15;123(6):928-939. doi: 10.1002/cncr.30423. Epub 2016 Nov 28.
6
A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can't Pay the Co-Pay.癌症幸存者财务毒性的系统评价：我们付不起自付费用。
Patient. 2017 Jun;10(3):295-309. doi: 10.1007/s40271-016-0204-x.
7
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.更新美国临床肿瘤学会价值框架：针对收到的评论进行的修订与思考
J Clin Oncol. 2016 Aug 20;34(24):2925-34. doi: 10.1200/JCO.2016.68.2518. Epub 2016 May 31.
8
NCCN Evidence Blocks.NCCN 证据块。
J Natl Compr Canc Netw. 2016 May;14(5 Suppl):616-9. doi: 10.6004/jnccn.2016.0177.
9
Characterizing health plan price estimator tools: findings from a national survey.描述健康计划价格估算工具：一项全国性调查的结果
Am J Manag Care. 2016 Feb;22(2):126-31.
10
The utility of cost discussions between patients with cancer and oncologists.癌症患者与肿瘤学家之间成本讨论的效用。
Am J Manag Care. 2015 Sep;21(9):607-15.
Zotero 插件